TY - JOUR
T1 - Role of central nervous system nitric oxide in the development of neurogenic pulmonary edema in rats
AU - Hamdy, Ossama
AU - Maekawa, Hiroshi
AU - Shimada, Yasuhiro
AU - Feng, Guo Gang
AU - Ishikawa, Naohisa
PY - 2001
Y1 - 2001
N2 - Objective: The present study was undertaken to evaluate roles of nitric oxide in the central nervous system in the development of neurogenic pulmonary edema. Nitric oxide donor compounds have been reported to be effective for controlling some kinds of pulmonary edema. Design: Randomized trial. Setting: Experimental university pharmacology laboratory. Subjects: Wistar rats anesthetized with pentobarbital. Interventions: Neurogenic pulmonary edema was induced by injections of fibrinogen and thrombin into the cisterna magna. Physiologic roles of nitric oxide were evaluated by using NG-nitro-L-arginine methyl ester (a nitric oxide synthase inhibitor) or L-arginine (a nitric oxide donor compound). Vagus nerves were either left intact or bilaterally severed 20 mins before the injections of fibrinogen and thrombin. Measurements and Main Results: Because enhanced sympathetic nerve activity mediates neurogenic pulmonary edema, the concentration of neuropeptide Y, a neurotransmitter, in edema fluid was measured by using enzyme-linked immunosorbent assay. To evaluate the severity of pulmonary edema and pulmonary vascular permeability, lung water content and protein concentration in edema fluid were analyzed. In rats with intact vagus nerves, injection of NG-nitro-L-arginine methyl ester into the cisterna magna worsened the pulmonary edema, whereas L-arginine had no effect. In contrast, in vagotomized rats, L-arginine abrogated pulmonary edema, whereas NG-nitro-L-arginine methyl ester exerted no influence. Likewise, the ratio of edema fluid protein to serum protein and the neuropeptide Y concentration were increased by NG-nitro-L-arginine methyl ester in rats with the vagus nerves intact and were diminished by L-arginine in vagotomized rats. Conclusions: Neurogenic pulmonary edema is characterized by elevated pulmonary vascular permeability and may be inhibited by nitric oxide production in the medulla oblongata.
AB - Objective: The present study was undertaken to evaluate roles of nitric oxide in the central nervous system in the development of neurogenic pulmonary edema. Nitric oxide donor compounds have been reported to be effective for controlling some kinds of pulmonary edema. Design: Randomized trial. Setting: Experimental university pharmacology laboratory. Subjects: Wistar rats anesthetized with pentobarbital. Interventions: Neurogenic pulmonary edema was induced by injections of fibrinogen and thrombin into the cisterna magna. Physiologic roles of nitric oxide were evaluated by using NG-nitro-L-arginine methyl ester (a nitric oxide synthase inhibitor) or L-arginine (a nitric oxide donor compound). Vagus nerves were either left intact or bilaterally severed 20 mins before the injections of fibrinogen and thrombin. Measurements and Main Results: Because enhanced sympathetic nerve activity mediates neurogenic pulmonary edema, the concentration of neuropeptide Y, a neurotransmitter, in edema fluid was measured by using enzyme-linked immunosorbent assay. To evaluate the severity of pulmonary edema and pulmonary vascular permeability, lung water content and protein concentration in edema fluid were analyzed. In rats with intact vagus nerves, injection of NG-nitro-L-arginine methyl ester into the cisterna magna worsened the pulmonary edema, whereas L-arginine had no effect. In contrast, in vagotomized rats, L-arginine abrogated pulmonary edema, whereas NG-nitro-L-arginine methyl ester exerted no influence. Likewise, the ratio of edema fluid protein to serum protein and the neuropeptide Y concentration were increased by NG-nitro-L-arginine methyl ester in rats with the vagus nerves intact and were diminished by L-arginine in vagotomized rats. Conclusions: Neurogenic pulmonary edema is characterized by elevated pulmonary vascular permeability and may be inhibited by nitric oxide production in the medulla oblongata.
KW - Central nervous system
KW - Fibrin
KW - L-arginine
KW - N-nitro-L-arginine
KW - Neurogenic pulmonary edema
KW - Neuropeptide Y
KW - Nitric oxide
KW - Sympathetic nerve
KW - Vagus nerve
KW - Vascular permeability
UR - https://www.scopus.com/pages/publications/0034984916
UR - https://www.scopus.com/inward/citedby.url?scp=0034984916&partnerID=8YFLogxK
U2 - 10.1097/00003246-200106000-00028
DO - 10.1097/00003246-200106000-00028
M3 - Article
C2 - 11395608
AN - SCOPUS:0034984916
SN - 0090-3493
VL - 29
SP - 1222
EP - 1228
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 6
ER -